Clinical Trial

The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 20, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the study is to test the effect of the administration of a dietary supplement consisting of epigallocatechin gallate (EGCG), vitamin B12 and folic acid in the treatment of infections with papilloma virus of the cervix.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-02-28; most recent amendment 2025-11-19.
Status change: Not Yet Recruiting → Recruiting 2024-03-15
Trial Details
NCT Number NCT06285357
Lead Sponsor Lo.Li.Pharma s.r.l
Conditions HPV Infection
Enrollment 100 participants
Start Date 2024-02-19
Primary Completion 2026-03 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-11-20